《大行報告》瑞信重申對中國市場「增持」評級 料內地有力控制好疫情
瑞信發表策略報告表示,重申對中國資本市場「增持」評級,指流動性過剩正升,估值水平顯示出買進的訊號。
該行相信內地政府需時處理新冠新一波的疫情,估計內地在今年11月召開中共「二十大」會議前都不會改變目前「動態清零」政策,並指內地自主研發的,料中國自主研發的mRNA(即信使核糖核酸)疫苗疫苗仍處測試階段,料一年後才會推出,該行估計相關風險因素後,或會令市場下調對中國GDP增長預測介乎0.5個至1個百分點。
瑞信認為中國有能力控制好新冠疫情,當局已批准輝瑞抗病毒治療程,並已調整新冠診療方案,指近期「封城」地區佔中國人口約3.5%、於GDP估比僅8%。該行亦料內地會進一步放鬆貨幣政策,同時料內地房地產市場不會進一步轉壞。
該行指,內地科技股預測市盈率估值便宜,盈利修正已處低谷。該行亦要可留意內地消費品牌企業,首選的股份包括華潤啤酒(00291.HK)、申洲(02313.HK)及珀萊雅(603605.SH)。(wl/s)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.